Crump Nicholas T, Milne Thomas A
Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Bioessays. 2025 Jun;47(6):e70006. doi: 10.1002/bies.70006. Epub 2025 Apr 8.
The precise regulation of the transcription of genes is essential for normal development and for the maintenance of life. Aberrant gene expression changes drive many human diseases. Despite this, we still do not completely understand how precise gene regulation is controlled in living systems. Enhancers are key regulatory elements that enable cells to specifically activate genes in response to environmental cues, or in a stage or tissue-specific manner. Any model of enhancer activity needs to answer two main questions: (1) how enhancers are able to identify and act on specific genes and (2) how enhancers influence transcription. To address these points, we first outline some of the basic principles that can be established from simpler prokaryotic systems, then discuss recent work on aberrant enhancer activity in leukemia. We argue that highly specific protein-protein interactions are a key driver of enhancer-promoter proximity, allowing enhancer-bound factors to directly act on RNA polymerase and activate transcription.
基因转录的精确调控对于正常发育和维持生命至关重要。异常的基因表达变化会引发许多人类疾病。尽管如此,我们仍然没有完全理解在生命系统中精确的基因调控是如何被控制的。增强子是关键的调控元件,使细胞能够响应环境信号,或以阶段或组织特异性的方式特异性地激活基因。任何增强子活性模型都需要回答两个主要问题:(1)增强子如何能够识别并作用于特定基因,以及(2)增强子如何影响转录。为了解决这些问题,我们首先概述一些可以从更简单的原核系统中确立的基本原理,然后讨论白血病中异常增强子活性的最新研究。我们认为,高度特异性的蛋白质-蛋白质相互作用是增强子与启动子接近的关键驱动因素,使结合在增强子上的因子能够直接作用于RNA聚合酶并激活转录。